Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedA site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.8%

- Check10 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check17 days agoChange DetectedThe site’s displayed revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check37 days agoChange DetectedThe history now records a new system revision: v3.7.0. The previous revision, v3.6.6, is removed from the history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now shows the latest revision as v3.6.6, replacing the prior v3.6.5 entry. This indicates a new version has been saved in the study's history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry labeled v3.6.5 has been added to the record history. The previous revision v3.6.4 was removed, reflecting an update to the page's version log rather than changes to study data.SummaryDifference0.1%

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.